KLRS - Allovir, Inc.
9.82
0.145 1.477%
Share volume: 41,326
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$9.68
0.14
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-09-2024 | 11-12-2024 | 03-07-2025 | 05-14-2025 | 11-12-2025 | |
| Assets | |||||||
| Total Assets | 144.143 M | 130.987 M | 122.530 M | 118.546 M | 103.092 M | 81.175 M | |
| Current Assets | 141.482 M | 129.938 M | 122.530 M | 118.546 M | 102.182 M | 78.183 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 54.491 M | 24.871 M | 4.995 M | 0.000 | 0.000 | 34.612 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 86.039 M | 104.741 M | 116.856 M | 118.289 M | 100.965 M | 42.387 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 2.661 M | 1.049 M | 0.000 | 0.000 | 910.000 K | 2.992 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 144.143 M | 130.987 M | 122.530 M | 118.546 M | 103.092 M | 81.175 M | |
| Total liabilities | 23.703 M | 10.695 M | 1.412 M | 5.239 M | 39.218 M | 39.310 M | |
| Total current liabilities | 7.656 M | 2.359 M | 1.412 M | 5.239 M | 7.142 M | 6.065 M | |
| Accounts Payable | 765.000 K | 110.000 K | 51.000 K | 247.000 K | 2.374 M | 494.000 K | |
| Other liabilities | 16.047 M | 8.336 M | 0.000 | 0.000 | 32.076 M | 33.245 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 16.047 M | 8.336 M | 0.000 | 0.000 | 32.076 M | 33.245 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 120.440 M | 120.292 M | 121.118 M | 113.307 M | 63.874 M | 41.865 M | |
| Common stock | 807.070 M | 812.999 M | 817.946 M | 828.404 M | 190.631 M | 191.860 M | |
| Retained earnings | -686.492 M | -692.568 M | -696.694 M | -714.962 M | -126.757 M | -150.001 M |